RemedyMeds
US$ 23.53
glp-1 agonist eli lilly stock soars on encouraging results for daily weight-loss pill Orforglipron: Eli Lilly's New Oral
Description
The clinically most relevant and important action of DPP-4 inhibitors is the endogenous elevation of the incretin hormone concentration of GLP-1 that consecutively leads to a glucose-dependent stimulation of insulin secretion and an inhibition of glucagon secretion (10)
Be sure to tell your healthcare provider about your medical history and all medications you take
Importantly, none of the studies reported any worsening of headaches with GLP-1 RAs
Stronger cardiovascular data: The SELECT trial provides robust evidence for cardiovascular protection
